The Application of Brain Stimulation in Psychiatric Disorders : An Overview

정신질환에서 뇌자극술의 적용

  • Roh, Daeyoung (Department of Psychiatry, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Kang, Lee Young (Department of Psychiatry, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Kim, Do Hoon (Department of Psychiatry, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital)
  • 노대영 (한림대학교 의과대학 춘천성심병원 정신건강의학교실) ;
  • 강리영 (한림대학교 의과대학 춘천성심병원 정신건강의학교실) ;
  • 김도훈 (한림대학교 의과대학 춘천성심병원 정신건강의학교실)
  • Received : 2017.06.09
  • Accepted : 2017.07.26
  • Published : 2017.11.30

Abstract

Based on advances in biotechnology and neuroscience, neuromodulation is poised to gain clinical importance as a treatment modality for psychiatric disorders. In addition to old-established electroconvulsive therapy (ECT), clinicians are expected to understand newer forms of neurostimulation, such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). Given the growing interest in non-invasive neuromodulation technologies, clinicians may seek sufficient information about neuromodulation to inform their clinical practice. A growing literature suggests that applications of non-invasive neuromodulation have evidence particularly for indications where treatments are currently insufficient, such as drug-resistant depression. However, positive neuromodulation studies require replication, and the precise interactions among stimulation, antidepressant medication, and psychotherapy are unknown. Further studies of long-term safety and the impact on the developing brain are needed. Non-invasive neuromodulatory devices could enable more individualized treatment. However, do-it-yourself (DIY) stimulation kits require a better understanding of the effects of more frequent patterns of stimulation and raise concerns about clinical supervision, regulation, and reimbursement. Wide spread enthusiasm for therapeutic potential of neuromodulation in clinical practice settings should be mitigated by the fact that there are still research gaps and challenges associated with non-invasive neuromodulatory devices.

Keywords

References

  1. Fink M. Meduna and the origins of convulsive therapy. Am J Psychiatry 1984;141:1034-1041. https://doi.org/10.1176/ajp.141.9.1034
  2. Dance A. Smart drugs: a dose of intelligence. Nature 2016;531:S2-S3. https://doi.org/10.1038/531S2a
  3. Lee YJ, Koo BH, Seo WS, Kim HG, Kim JY, Cheon EJ. Repetitive transcranial magnetic stimulation of the supplementary motor area in treatment-resistant obsessive-compulsive disorder: an open-label pilot study. J Clin Neurosci 2017;44:264-268. https://doi.org/10.1016/j.jocn.2017.06.057
  4. Kang JI, Lee H, Jhung K, Kim KR, An SK, Yoon KJ, et al. Frontostriatal connectivity changes in major depressive disorder after repetitive transcranial magnetic stimulation: a randomized sham-controlled study. J Clin Psychiatry 2016;77:e1137-e1143.
  5. Lee TY, Lee J, Kim M, Kwon JS. The effect of transcranial direct current stimulation on auditory hallucination in patients with schizophrenia. Schizophr Res 2017 [Epub ahead of print].
  6. Guleyupoglu B, Schestatsky P, Edwards D, Fregni F, Bikson M. Classification of methods in transcranial electrical stimulation (tES) and evolving strategy from historical approaches to contemporary innovations. J Neurosci Methods 2013;219:297-311. https://doi.org/10.1016/j.jneumeth.2013.07.016
  7. Weiner RD, Reti IM. Key updates in the clinical application of electroconvulsive therapy. Int Rev Psychiatry 2017;29:54-62. https://doi.org/10.1080/09540261.2017.1309362
  8. Torring N, Sanghani SN, Petrides G, Kellner CH, Ostergaard SD. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand 2017;135:388-397. https://doi.org/10.1111/acps.12721
  9. American Psychiatric Association, Task Force on Electroconvulsive Therapy. The practice of ECT: Recommendations for treatment, training and privileging. Convuls Ther 1990;6:85-120.
  10. Doris A, Ebmeier K, Shajahan P. Depressive illness. Lancet 1999;354:1369-1375. https://doi.org/10.1016/S0140-6736(99)03121-9
  11. Naesstrom M, Blomstedt P, Bodlund O. A systematic review of psychiatric indications for deep brain stimulation, with focus on major depressive and obsessive-compulsive disorder. Nord J Psychiatry 2016;70:483-491. https://doi.org/10.3109/08039488.2016.1162846
  12. Nangunoori R, Tomycz ND, Quigley M, Oh MY, Whiting DM. Deep brain stimulation for psychiatric diseases: a pooled analysis of published studies employing disease-specific standardized outcome scales. Stereotact Funct Neurosurg 2013;91:345-354. https://doi.org/10.1159/000351156
  13. Roh D, Chang WS, Chang JW, Kim CH. Long-term follow-up of deep brain stimulation for refractory obsessive-compulsive disorder. Psychiatry Res 2012;200:1067-1070. https://doi.org/10.1016/j.psychres.2012.06.018
  14. Lapidus KA, Kopell BH, Ben-Haim S, Rezai AR, Goodman WK. History of psychosurgery: a psychiatrist's perspective. World Neurosurg 2013;80:S27.e1-e16. https://doi.org/10.1016/j.wneu.2011.09.026
  15. Eljamel S. Vagus nerve stimulation for major depressive episodes. Prog Neurol Surg 2015;29:53-63.
  16. Manta S, El Mansari M, Debonnel G, Blier P. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol 2013;16:459-470. https://doi.org/10.1017/S1461145712000387
  17. Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl) 2013;6:17-35.
  18. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713-728. https://doi.org/10.1016/S0893-133X(01)00271-8
  19. Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015;14:64-73. https://doi.org/10.1002/wps.20199
  20. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010;67:507-516. https://doi.org/10.1001/archgenpsychiatry.2010.46
  21. Fried PJ, Rushmore RJ 3rd, Moss MB, Valero-Cabre A, Pascual-Leone A. Causal evidence supporting functional dissociation of verbal and spatial working memory in the human dorsolateral prefrontal cortex. Eur J Neurosci 2014;39:1973-1981. https://doi.org/10.1111/ejn.12584
  22. Klawansky S, Yeung A, Berkey C, Shah N, Phan H, Chalmers TC. Meta-analysis of randomized controlled trials of cranial electrostimulation. Efficacy in treating selected psychological and physiological conditions. J Nerv Ment Dis 1995;183:478-484. https://doi.org/10.1097/00005053-199507000-00010
  23. Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. J Affect Disord 2014;164:171-177. https://doi.org/10.1016/j.jad.2014.04.029
  24. Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, et al. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: a three week double blind pilot study. J Psychiatr Res 2015;70:98-105. https://doi.org/10.1016/j.jpsychires.2015.08.016
  25. De Felice EA. Cranial electrotherapy stimulation (CES) in the treatment of anxiety and other stress-related disorders: a review of controlled clinical trials. Stress Medicine 1997;13:31-42. https://doi.org/10.1002/(SICI)1099-1700(199701)13:1<31::AID-SMI715>3.0.CO;2-G
  26. Datta A, Dmochowski JP, Guleyupoglu B, Bikson M, Fregni F. Cranial electrotherapy stimulation and transcranial pulsed current stimulation: a computer based high-resolution modeling study. Neuroimage 2013;65:280-287. https://doi.org/10.1016/j.neuroimage.2012.09.062
  27. Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am 2013;36:169-176. https://doi.org/10.1016/j.psc.2013.01.006
  28. Paulus W. Transcranial electrical stimulation (tES - tDCS; tRNS, tACS) methods. Neuropsychol Rehabil 2011;21:602-617. https://doi.org/10.1080/09602011.2011.557292
  29. Rush AJ, Siefert SE. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp Neurol 2009;219:36-43. https://doi.org/10.1016/j.expneurol.2009.04.015
  30. Priori A, Berardelli A, Rona S, Accornero N, Manfredi M. Polarization of the human motor cortex through the scalp. Neuroreport 1998;9:2257-2260. https://doi.org/10.1097/00001756-199807130-00020
  31. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000;527 Pt 3:633-639. https://doi.org/10.1111/j.1469-7793.2000.t01-1-00633.x
  32. Kekic M, Boysen E, Campbell IC, Schmidt U. A systematic review of the clinical efficacy of transcranial direct current stimulation (tDCS) in psychiatric disorders. J Psychiatr Res 2016;74:70-86. https://doi.org/10.1016/j.jpsychires.2015.12.018
  33. Conti CL, Nakamura-Palacios EM. Bilateral transcranial direct current stimulation over dorsolateral prefrontal cortex changes the drugcued reactivity in the anterior cingulate cortex of crack-cocaine addicts. Brain Stimul 2014;7:130-132. https://doi.org/10.1016/j.brs.2013.09.007
  34. da Silva MC, Conti CL, Klauss J, Alves LG, do Nascimento Cavalcante HM, Fregni F, et al. Behavioral effects of transcranial direct current stimulation (tDCS) induced dorsolateral prefrontal cortex plasticity in alcohol dependence. J Physiol Paris 2013;107:493-502. https://doi.org/10.1016/j.jphysparis.2013.07.003
  35. Manenti R, Brambilla M, Benussi A, Rosini S, Cobelli C, Ferrari C, et al. Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. Mov Disord 2016;31:715-724. https://doi.org/10.1002/mds.26561
  36. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 2001;57:1899-1901. https://doi.org/10.1212/WNL.57.10.1899
  37. Nitsche MA, Liebetanz D, Antal A, Lang N, Tergau F, Paulus W. Modulation of cortical excitability by weak direct current stimulation--technical, safety and functional aspects. Suppl Clin Neurophysiol 2003;56:255-276.
  38. Priori A. Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability. Clin Neurophysiol 2003;114:589-595. https://doi.org/10.1016/S1388-2457(02)00437-6
  39. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003;553:293-301. https://doi.org/10.1113/jphysiol.2003.049916
  40. Paulus W, Rothwell JC. Membrane resistance and shunting inhibition: where biophysics meets state-dependent human neurophysiology. J Physiol 2016;594:2719-2728. https://doi.org/10.1113/JP271452
  41. Matsumoto H, Ugawa Y. Adverse events of tDCS and tACS: a review. Clinical Neurophysiology Practice 2017;2:19-25. https://doi.org/10.1016/j.cnp.2016.12.003
  42. Galvez V, Alonzo A, Martin D, Mitchell PB, Sachdev P, Loo CK. Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS). J ECT 2011;27:256-258. https://doi.org/10.1097/YCT.0b013e3182012b89
  43. Brunoni AR, Ferrucci R, Bortolomasi M, Scelzo E, Boggio PS, Fregni F, et al. Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the major depressive episode: findings from a naturalistic study. Eur Psychiatry 2013;28:356-361. https://doi.org/10.1016/j.eurpsy.2012.09.001
  44. Sale MV, Mattingley JB, Zalesky A, Cocchi L. Imaging human brain networks to improve the clinical efficacy of non-invasive brain stimulation. Neurosci Biobehav Rev 2015;57:187-198. https://doi.org/10.1016/j.neubiorev.2015.09.010
  45. Llinas RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A 1999;96:15222-15227. https://doi.org/10.1073/pnas.96.26.15222
  46. Schulman JJ, Cancro R, Lowe S, Lu F, Walton KD, Llinas RR. Imaging of thalamocortical dysrhythmia in neuropsychiatry. Front Hum Neurosci 2011;5:69.
  47. Klimesch W. ${\alpha}$-band oscillations, attention, and controlled access to stored information. Trends Cogn Sci 2012;16:606-617. https://doi.org/10.1016/j.tics.2012.10.007
  48. Jausovec N, Jausovec K. Increasing working memory capacity with theta transcranial alternating current stimulation (tACS). Biol Psychol 2014;96:42-47. https://doi.org/10.1016/j.biopsycho.2013.11.006
  49. Hoy KE, Bailey N, Arnold S, Windsor K, John J, Daskalakis ZJ, et al. The effect of ${\gamma}$-tACS on working memory performance in healthy controls. Brain Cogn 2015;101:51-56. https://doi.org/10.1016/j.bandc.2015.11.002
  50. Iuculano T, Cohen Kadosh R. The mental cost of cognitive enhancement. J Neurosci 2013;33:4482-4486. https://doi.org/10.1523/JNEUROSCI.4927-12.2013
  51. Sarkar A, Dowker A, Cohen Kadosh R. Cognitive enhancement or cognitive cost: trait-specific outcomes of brain stimulation in the case of mathematics anxiety. J Neurosci 2014;34:16605-16610. https://doi.org/10.1523/JNEUROSCI.3129-14.2014
  52. Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Goulart A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013;70:383-391. https://doi.org/10.1001/2013.jamapsychiatry.32
  53. Gandiga PC, Hummel FC, Cohen LG. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 2006;117:845-850. https://doi.org/10.1016/j.clinph.2005.12.003
  54. Wallace D, Cooper NR, Paulmann S, Fitzgerald PB, Russo R. Perceived comfort and blinding efficacy in randomised sham-controlled transcranial direct current stimulation (tDCS) Trials at 2 mA in Young and Older Healthy Adults. PLoS One 2016;11:e0149703. https://doi.org/10.1371/journal.pone.0149703
  55. O'Connell NE, Cossar J, Marston L, Wand BM, Bunce D, Moseley GL, et al. Rethinking clinical trials of transcranial direct current stimulation: participant and assessor blinding is inadequate at intensities of 2mA. PLoS One 2012;7:e47514. https://doi.org/10.1371/journal.pone.0047514